Related Experiment Video
Updated: May 28, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
Cholesterol embolization syndrome
Muhamed Saric1, Itzhak Kronzon
1Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York, New York 10016, USA. muhamed.saric@nyumc.org
Insights
Cholesterol embolization syndrome (CES) occurs when plaque embolizes, causing organ damage. Diagnosis relies on biopsy, and treatment focuses on supportive care and managing underlying atherosclerosis.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Neurology
Background:
- Cholesterol embolization syndrome (CES), also known as atheroembolism, arises from the embolization of atherosclerotic plaque contents.
- This condition leads to ischemic end-organ damage, affecting multiple organ systems.
Purpose of the Study:
- To comprehensively review cholesterol embolization syndrome (CES).
- To detail its risk factors, pathophysiology, clinical presentation, diagnostic methods, and current treatment strategies.
Main Methods:
- Literature review of studies on cholesterol embolization syndrome.
- Analysis of clinical manifestations, diagnostic approaches, and therapeutic interventions.
Main Results:
- CES presents with constitutional symptoms, systemic inflammation, and specific signs like livedo reticularis and blue-toe syndrome.
- Diagnosis is confirmed via organ biopsy; no specific laboratory test exists.
- Hollenhorst plaques on retinal exam can support the diagnosis.
Conclusions:
- Currently, no specific diagnostic test beyond biopsy is available for CES.
- Effective treatments for CES itself are still under development.
- Management involves supportive care and addressing underlying atherosclerosis and arterial ischemia.
Purpose Of Review:
To describe cholesterol embolization syndrome (CES) and its risk factors, pathophysiology, clinical presentation, diagnosis and treatment.
Recent Findings:
To date, no specific diagnostic test (other than biopsy) for CES has been developed. Effective treatments for CES are yet to be developed.
Summary:
CES (also referred to as cholesterol crystal embolization, atheromatous embolization or atheroembolism) occurs when cholesterol crystals and other contents of an atherosclerotic plaque embolize from a large proximal artery to smaller distal arteries, causing ischemic end-organ damage. Clinical manifestations of CES include constitutional symptoms (fever, anorexia, weight loss, fatigue and myalgias), signs of systemic inflammation (anemia, thrombocytopenia leukocytosis, high erythrocyte sedimentation rate, elevated levels of C-reactive protein, hypocomplementemia), hypereosinophilia, eosinophiluria, acute onset of diffuse neurologic deficit, amaurosis fugax, acute renal failure, gut ischemia, livedo reticularis and blue-toe syndrome. CES may occur spontaneously or after an arterial procedure. There is no specific laboratory test for CES. Retinal exam demonstrating Hollenhorst plaques supports the diagnosis of CES. Biopsy of target organs (usually skin, skeletal muscles or kidneys) is the only means of confirming the diagnosis of CES. Treatment consists of supportive care and general management of atherosclerosis and arterial ischemia.
Related Concept Videos
Cholecystitis
Cholesterol: Significance and Regulation
Considering cholesterol and...
Venous Thrombosis I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Endoscopic Procedures V: ERCP
Patient...
Pulmonary Embolism I: Introduction